Molbio Diagnostics IPO logo

Molbio Diagnostics IPO GMP Today

Upcoming

Molbio Diagnostics IPO opens on 10 August 2026. Molbio Diagnostics IPO GMP is Rs 170.00 today. Listing price estimate is Rs 977.00 (issue price Rs 807.00). Listing gain estimate: 21.07%.

Issue Price

Rs 807.00

GMP Today

Rs 170.00

GMP %

+21.07%

Listing Price

Rs 977.00

Listing Gain / Lot

Rs 3,060.00

Listing Date

17 Aug 2026

Molbio Diagnostics IPO GMP Day Wise

GMP for Molbio Diagnostics IPO started at Rs 0 on 4 August 2026 and stood at Rs 170 on 6 August 2026. The sharpest single-day jump was from Rs 0 on 4 Aug 2026 to Rs 170 on 5 Aug 2026. The upward move through the subscription window usually reflects building demand across investor categories rather than a one-day spike. GMP typically moves more in the final two to three days before the close date, especially after QIB and HNI bids come in.

DateIssue PriceGMPListing PriceEstimated Profit
6 Aug 2026TodayRs 807.00Rs 170.00Rs 977.00 (+21.07%)Rs 3,060.00
5 Aug 2026Rs 807.00Rs 170.00Rs 977.00 (+21.07%)Rs 3,060.00
4 Aug 2026Rs 807.00Rs 0.00Rs 807.00 (+0.00%)Rs 0.00

Molbio Diagnostics IPO Listing Price

Based on today's GMP, Molbio Diagnostics IPO listing price estimate is Rs 977.00 per share (issue price Rs 807.00 + GMP Rs 170.00).

Actual listing price will be known on 17 August 2026 when the stock lists on NSE/BSE.

Molbio Diagnostics IPO Listing Gain

Lot size: 18 shares

GMP today: Rs 170.00

Estimated listing gain per lot: Rs 170.00 × 18 = Rs 3,060.00

GMP at roughly 21.1% suggests solid informal demand. The grey market expects the stock to list noticeably above the issue price.

GMP has moved up over the tracked period. Steady increases through the subscription window are usually a stronger signal than a single-day spike.

GMP is unofficial. Listing gain can differ on listing day.

Molbio Diagnostics IPO Subscription Status

GMP and subscription numbers often move together. When institutional and HNI demand is strong, grey market participants usually price in a higher premium. Current overall subscription for Molbio Diagnostics IPO is -. Compare this with the GMP trend to see if demand aligns. The GMP move around 5 Aug 2026 may reflect how the market reacted once the subscription window activity picked up after 10 Aug 2026.

See live figures on the Molbio Diagnostics IPO Subscription Status page.

Molbio Diagnostics IPO Details

FieldValue
Price Band₹768.0 - ₹807.0
Issue Size₹939.70 Cr
Lot Size18 shares
IPO TypeMainboard
Open Date10 Aug 2026
Close Date12 Aug 2026
Listing Date17 Aug 2026
Subscription-

Molbio Diagnostics IPO full details (financials, peers, review).

About Molbio Diagnostics IPO

No company information available

Molbio Diagnostics IPO IPO Pages

Open related pages for this IPO: details, GMP, subscription, allotment, review, FAQ, registrar, timeline, and news.

Advertisement

Molbio Diagnostics IPO GMP FAQs

What is Molbio Diagnostics IPO GMP today?

Molbio Diagnostics IPO GMP is ₹170 as of 6 August 2026, 10:17 AM IST. At issue price ₹807, that is +21.07% expected listing gain in the grey market.

What is Molbio Diagnostics IPO grey market premium (GMP)?

The grey market premium (GMP) for Molbio Diagnostics IPO is ₹170 today. GMP is the unofficial premium traders pay above the issue price of ₹807 before listing on NSE/BSE.

What is Molbio Diagnostics IPO expected returns?

Molbio Diagnostics IPO expected returns based on today's GMP are +21.07% over the issue price of ₹807. Estimated listing price is ₹977 per share. Actual listing gain on 17 August 2026 may differ.

What is the estimated listing price of Molbio Diagnostics IPO?

Based on today's GMP, Molbio Diagnostics IPO estimated listing price is ₹977 per share (issue price ₹807 + GMP ₹170). The actual listing price will be set on 17 August 2026 when trading starts.

What is the expected profit per lot in Molbio Diagnostics IPO?

At GMP of ₹170 and lot size of 18 shares, estimated grey market profit is ₹3,060 (1 lot × 18 shares × ₹170). This is unofficial and not guaranteed on listing day.

Will Molbio Diagnostics IPO list at GMP price?

Molbio Diagnostics IPO may list around ₹977 based on current GMP of ₹170, but listing at exact grey market price is not guaranteed. GMP is unofficial. On 17 August 2026, the opening price depends on market sentiment, final subscription, and index levels.

What is Molbio Diagnostics IPO issue price and lot size?

Molbio Diagnostics IPO issue price is ₹807 per share (price band ₹768.0 - ₹807.0). Lot size is 18 shares. Minimum application is 1 lot.

When is Molbio Diagnostics IPO listing date?

Molbio Diagnostics IPO is expected to list on 17 August 2026 on NSE and BSE. GMP can still move until listing day.

What is Molbio Diagnostics IPO GMP high and low?

Molbio Diagnostics IPO GMP made a high of ₹170 on 6 Aug 2026 and a low of ₹0 on 4 Aug 2026 in tracked grey market data.

Can Molbio Diagnostics IPO GMP change after subscription closes?

Yes. Molbio Diagnostics IPO closed on 12 August 2026. GMP often moves until listing (17 August 2026) based on allotment buzz, market mood, and news. Keep this page handy for the latest figure.

What is Molbio Diagnostics IPO subscription status?

Live category-wise subscription for Molbio Diagnostics IPO is on the Molbio Diagnostics IPO Subscription Status page on IPOwiz, including QIB, NII, and retail figures.

How to check Molbio Diagnostics IPO allotment status?

You can check Molbio Diagnostics IPO allotment with your PAN on the Molbio Diagnostics IPO Allotment Status page, the registrar site, BSE, or the IPOwiz App.

Sources

We match Molbio Diagnostics IPO IPO numbers with official sources. For final dates and allotment results, double-check the registrar or exchange.

  • SEBIRules for IPO allotment and disclosures in India
  • NSEExchange notices, bidding data, and listing updates
  • BSEExchange notices and IPO allotment check tools
  • RHP / Offer DocumentCheck the company RHP on NSE/BSE or the IPO detail page
  • IPO RegistrarRegistrar details are on the allotment page for this IPO

Also read our Editorial Policy, How GMP is calculated, and How allotment chances work.

Reviewed by

Dinesh Agrawal · Lead IPO Analyst

15+ years in Indian markets and IPO research. He reviews GMP figures before they go live.